2023
DOI: 10.3390/ph16020216
|View full text |Cite
|
Sign up to set email alerts
|

Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders

Abstract: Neurodegenerative disorders (NDDs) are major health issues in Western countries. Despite significant efforts, no effective therapeutics for NDDs exist. Several drugs that target epigenetic mechanisms (epidrugs) have been recently developed for the treatment of NDDs, and several of these are currently being tested in clinical trials. Furthermore, various bioproducts have shown important biological effects for the potential prevention and treatment of these disorders. Here, we review the use of natural products … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 206 publications
0
6
0
Order By: Relevance
“…However, a comprehensive understanding of the specific epigenetic changes and their functional consequences in different neurodegenerative disorders remains an area of active research. Unraveling the complexities of epigenetic regulation in these diseases may lead to identifying biomarkers and novel therapeutic targets, ultimately providing hope for more effective treatments in the future [ 121 , 140 , 141 ].…”
Section: Resultsmentioning
confidence: 99%
“…However, a comprehensive understanding of the specific epigenetic changes and their functional consequences in different neurodegenerative disorders remains an area of active research. Unraveling the complexities of epigenetic regulation in these diseases may lead to identifying biomarkers and novel therapeutic targets, ultimately providing hope for more effective treatments in the future [ 121 , 140 , 141 ].…”
Section: Resultsmentioning
confidence: 99%
“…In fact, environmental factors may influence the experience-driven synaptic activity leading to long-lasting modifications of neural circuits and neuronal properties in the adult brain [5]. Mechanisms such as DNA methylation, chromatin remodeling/histone modifications, and microRNA regulation are responsible for the stability and accessibility to the chromatin, thus controlling gene expression [56]. Deciphering the pathological mechanisms that underlie neuropsychiatric disorders, along with unraveling the interaction between genetics and the environment, holds the key to tailoring targeted treatments.…”
Section: Discussionmentioning
confidence: 99%
“…The possible use in the future of drugs or interventions capable of modifying epigenetic alterations contributing to post-menopausal conditions/diseases in a controlled manner (e.g., removal, addition) may be a feasible avenue for research going forward. Such drugs have been proposed to be applied in conditions affecting bone [210], cancer [211,212], neurodegenerative disorders [213,214], cardiovascular conditions [215,216], and healthy aging [217]. The development of such "epi-drugs" is not without challenges [218], particularly since such interventions will have to be personalized for post-menopausal conditions that arise in different tissues, may not result from a single phenotypic pattern, and may occur in conjunction with multiple co-morbidities as the individual ages.…”
Section: Conclusion and The Way Forwardmentioning
confidence: 99%